These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24380762)

  • 21. Herpes simplex virus 1 counteracts tetherin restriction via its virion host shutoff activity.
    Zenner HL; Mauricio R; Banting G; Crump CM
    J Virol; 2013 Dec; 87(24):13115-23. PubMed ID: 24067977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza A virus neuraminidase protein enhances cell survival through interaction with carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) protein.
    Gaur P; Ranjan P; Sharma S; Patel JR; Bowzard JB; Rahman SK; Kumari R; Gangappa S; Katz JM; Cox NJ; Lal RB; Sambhara S; Lal SK
    J Biol Chem; 2012 Apr; 287(18):15109-17. PubMed ID: 22396546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. H9N2 Influenza Virus Infections in Human Cells Require a Balance between Neuraminidase Sialidase Activity and Hemagglutinin Receptor Affinity.
    Arai Y; Elgendy EM; Daidoji T; Ibrahim MS; Ono T; Sriwilaijaroen N; Suzuki Y; Nakaya T; Matsumoto K; Watanabe Y
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lateral Organization of Influenza Virus Proteins in the Budozone Region of the Plasma Membrane.
    Leser GP; Lamb RA
    J Virol; 2017 May; 91(9):. PubMed ID: 28202765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-Dimensional Structural Characterization of HIV-1 Tethered to Human Cells.
    Strauss JD; Hammonds JE; Yi H; Ding L; Spearman P; Wright ER
    J Virol; 2016 Feb; 90(3):1507-21. PubMed ID: 26582000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 2nd sialic acid-binding site of influenza A virus neuraminidase is an important determinant of the hemagglutinin-neuraminidase-receptor balance.
    Du W; Guo H; Nijman VS; Doedt J; van der Vries E; van der Lee J; Li Z; Boons GJ; van Kuppeveld FJM; de Vries E; Matrosovich M; de Haan CAM
    PLoS Pathog; 2019 Jun; 15(6):e1007860. PubMed ID: 31181126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation.
    Mangeat B; Gers-Huber G; Lehmann M; Zufferey M; Luban J; Piguet V
    PLoS Pathog; 2009 Sep; 5(9):e1000574. PubMed ID: 19730691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-Linked Glycan Sites on the Influenza A Virus Neuraminidase Head Domain Are Required for Efficient Viral Incorporation and Replication.
    Östbye H; Gao J; Martinez MR; Wang H; de Gier JW; Daniels R
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tetherin/BST-2: Restriction Factor or Immunomodulator?
    Li SX; Barrett BS; Guo K; Santiago ML
    Curr HIV Res; 2016; 14(3):235-46. PubMed ID: 26957198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influenza virus neuraminidase protein transmembrane and head domains have coevolved.
    da Silva DV; Nordholm J; Dou D; Wang H; Rossman JS; Daniels R
    J Virol; 2015 Jan; 89(2):1094-104. PubMed ID: 25378494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles.
    Chen BJ; Leser GP; Morita E; Lamb RA
    J Virol; 2007 Jul; 81(13):7111-23. PubMed ID: 17475660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The M segment of the 2009 pandemic influenza virus confers increased neuraminidase activity, filamentous morphology, and efficient contact transmissibility to A/Puerto Rico/8/1934-based reassortant viruses.
    Campbell PJ; Danzy S; Kyriakis CS; Deymier MJ; Lowen AC; Steel J
    J Virol; 2014 Apr; 88(7):3802-14. PubMed ID: 24429367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influenza A virus does not encode a tetherin antagonist with Vpu-like activity and induces IFN-dependent tetherin expression in infected cells.
    Winkler M; Bertram S; Gnirß K; Nehlmeier I; Gawanbacht A; Kirchhoff F; Ehrhardt C; Ludwig S; Kiene M; Moldenhauer AS; Goedecke U; Karsten CB; Kühl A; Pöhlmann S
    PLoS One; 2012; 7(8):e43337. PubMed ID: 22952667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Release of filamentous and spherical influenza A virus is not restricted by tetherin.
    Bruce EA; Abbink TE; Wise HM; Rollason R; Galao RP; Banting G; Neil SJ; Digard P
    J Gen Virol; 2012 May; 93(Pt 5):963-969. PubMed ID: 22258861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuation of an influenza A virus due to alteration of its hemagglutinin-neuraminidase functional balance in mice.
    Gen F; Yamada S; Kato K; Akashi H; Kawaoka Y; Horimoto T
    Arch Virol; 2013 May; 158(5):1003-11. PubMed ID: 23247916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein.
    Vigan R; Neil SJ
    J Virol; 2010 Dec; 84(24):12958-70. PubMed ID: 20926557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of the Cytoplasmic Determinants of Vpu to the Expansion of Virus-Containing Compartments in HIV-1-Infected Macrophages.
    Leymarie O; Lepont L; Versapuech M; Judith D; Abelanet S; Janvier K; Berlioz-Torrent C
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza A and B virus-like particles produced in mammalian cells are highly immunogenic and induce functional antibodies.
    Buffin S; Peubez I; Barrière F; Nicolaï MC; Tapia T; Dhir V; Forma E; Sève N; Legastelois I
    Vaccine; 2019 Oct; 37(46):6857-6867. PubMed ID: 31590935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation.
    Morrison JH; Guevara RB; Marcano AC; Saenz DT; Fadel HJ; Rogstad DK; Poeschla EM
    J Virol; 2014 Mar; 88(6):3255-72. PubMed ID: 24390322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal.
    Lopez LA; Yang SJ; Hauser H; Exline CM; Haworth KG; Oldenburg J; Cannon PM
    J Virol; 2010 Jul; 84(14):7243-55. PubMed ID: 20444895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.